Lv3
330 积分 2024-04-20 加入
A Unique Approach to Design Potent and Selective Cyclic Adenosine Monophosphate Response Element Binding Protein, Binding Protein (CBP) Inhibitors
6个月前
已完结
A patent review on HMGB1 inhibitors for the treatment of liver diseases
7个月前
已完结
Nanoparticle-mediated immunogenic cell death for cancer immunotherapy
7个月前
已完结
N-glycosylation of High Mobility Group Box 1 protein (HMGB1) modulates the interaction with glycyrrhizin: A molecular modeling study
7个月前
已完结
Enhancers are activated by p300/CBP activity-dependent PIC assembly, RNAPII recruitment, and pause release
7个月前
已完结
皖公网安备34019202002308
